Clinical outcomes by nephrectomy status in METEOR, a randomized phase 3 trial of cabozantinib (cabo) vs everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC) Meeting Abstract
| Authors: | Tannir, N. M.; Powles, T.; Escudier, B. J.; Donskov, F.; Grünwald, V.; Sternberg, C. N.; Schmidinger, M.; Schoffski, P.; Szczylik, C.; Peltola, K. J.; Nosov, D.; Melichar, B.; Clary, D. O.; Scheffold, C.; Motzer, R. J.; Choueiri, T. K. |
| Abstract Title: | Clinical outcomes by nephrectomy status in METEOR, a randomized phase 3 trial of cabozantinib (cabo) vs everolimus (eve) in patients (pts) with advanced renal cell carcinoma (RCC) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 254s |
| Language: | English |
| ACCESSION: | WOS:000411931702070 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.4570 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4570 -- Source: Wos |
